EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond

Hyo-In Rhyou iD, Young-Hee Nam iD, Jung-Won Park iD, Hae-Sim Park iD

Yonsei Medical Journal · 2026

DOI: 10.3349/ymj.2025.0369 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Yonsei Medical Journal, 2026. Verfasst von Hyo-In Rhyou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Haeundae Paik Hospital, Inje University School of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Chronic Urticaria, Immunoglobulin E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic spontaneous urticaria (CSU) is associated with a substantial disease burden due to its prolonged course and significant impairment of quality of life. The diagnostic process for CSU involves confirming the diagnosis itself and identifying disease phenotypes or endotypes, cofactors, and comorbid conditions, which may affect disease activity and severity. Immunoglobulin E (IgE) and non-IgE-mediated mast cell degranulation are the major pathogenic mechanisms of CSU, where FcεRIα, a high-affinity IgE receptor, is the critical therapeutic target. Although the first-line treatment for CSU is typically second-generation H1-antihistamines, anti-IgE antibodies are recommended for patients who are refractory to up-dosed antihistamines. However, some patients with autoimmune phenotypes show incomplete responses. Recently, dupilumab, an anti-interleukin (IL)-4/IL-13 receptor antibody that inhibits type 2 inflammation, was approved by the US Food and Drug Administration. Patients with autoimmune phenotypes treated with Bruton's tyrosine kinase inhibitors have shown promising efficacy. Additionally, emerging biological agents, such as anti-KIT antibodies targeting mast cell activation and survival, and novel anti-IgE therapies (e.g., YH35324), are currently under investigation and are anticipated to become potential therapeutic options. This review provides an update on the pathogenic mechanisms of CSU, including IgE- and non-IgE-mediated mechanisms, and suggests potential therapeutic targets for improving clinical remission rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaImmunoglobulin EHumansMast CellsReceptors, IgEAnimalsChronic DiseaseAntibodies, Anti-Idiotypic

Stichwörter der Autor:innen

Chronic spontaneous urticariaFc-epsilon receptoranti-immunoglobulin E antibodiesautoimmunityimmunoglobulin Emast cell

Substanzen

Immunoglobulin EReceptors, IgEanti-IgE antibodiesAntibodies, Anti-Idiotypic

Autor:innen und Institutionen

  • Department of Internal Medicine, Haeundae Paik Hospital, Inje University School of Medicine, Busan, Korea.
  • Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.
  • Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Ajou University Medical Center, Suwon, Korea. hspark@ajou.ac.kr.

ORCID-Profile: Hyo-In Rhyou, Young-Hee Nam, Jung-Won Park, Hae-Sim Park

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Rhyou, H. I., Nam, Y. H., Park, J. W., & Park, H. S. (2026). Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2025.0369

Vancouver

Rhyou HI, Nam YH, Park JW, Park HS. Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond. Yonsei Medical Journal. 2026. doi:10.3349/ymj.2025.0369

BibTeX
@article{Rhyou2026,
  author = {Rhyou, Hyo-In and Nam, Young-Hee and Park, Jung-Won and Park, Hae-Sim},
  title = {Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond},
  journal = {Yonsei Medical Journal},
  year = {2026},
  doi = {10.3349/ymj.2025.0369}
}
Kostenlos starten →